{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:14:22Z","timestamp":1785255262097,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.revmed.2018.02.002","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T23:06:22Z","timestamp":1520463982000},"page":"256-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["La fi\u00e8vre r\u00e9currente li\u00e9e au r\u00e9cepteur 1\u00a0du TNF (TNF receptor associated periodic syndrome \u2013\u00a0TRAPS)"],"prefix":"10.1016","volume":"39","author":[{"given":"S.","family":"Georgin-Lavialle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Kone-Paut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Delaleu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sarrabay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Grateau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Touitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Hentgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2018.02.002_bib0005","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1136\/annrheumdis-2013-204184","article-title":"The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158\u00a0cases from the Eurofever\/EUROTRAPS international registry","volume":"73","author":"Lachmann","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2018.02.002_bib0010","article-title":"Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS)","author":"Bachetti","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2018.02.002_bib0015","article-title":"Autophagy dysfunction in autoinflammatory diseases","author":"Hua","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.revmed.2018.02.002_bib0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55kDa TNF receptor, TNFRSF1A, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.revmed.2018.02.002_bib0025","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/art.38727","article-title":"Brief Report: Involvement of TNFRSF11A molecular defects in autoinflammatory disorders","volume":"66","author":"J\u00e9ru","year":"2014","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.revmed.2018.02.002_bib0030","first-page":"469","article-title":"Familial Hibernian fever","volume":"51","author":"Williamson","year":"1982","journal-title":"Q J Med"},{"key":"10.1016\/j.revmed.2018.02.002_bib0035","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/art.33416","article-title":"Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study","volume":"64","author":"Bulua","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2018.02.002_bib0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/rheumatology\/keg070","volume":"42","author":"Drewe","year":"2003","journal-title":"Rheumatol Oxf"},{"key":"10.1016\/j.revmed.2018.02.002_bib0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/978-1-4419-6612-4_43","article-title":"Lessons from anti-TNF biologics: infliximab failure in a TRAPS family with the T50M mutation in TNFRSF1A","volume":"691","author":"Nedjai","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.revmed.2018.02.002_bib0050","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1136\/ard.2010.144279","article-title":"Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome","volume":"70","author":"Quillinan","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2018.02.002_bib0055","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/sj.embor.7400687","article-title":"Tumour necrosis factor receptor 1\u00a0mediates endoplasmic reticulum stress-induced activation of the MAP kinase JNK","volume":"7","author":"Yang","year":"2006","journal-title":"EMBO Rep"},{"key":"10.1016\/j.revmed.2018.02.002_bib0060","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/acr.23120","article-title":"International retrospective chart review of treatment patterns in severe familial mediterranean fever, tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency\/Hyperimmunoglobulinemia D Syndrome","volume":"69","author":"Ozen","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.revmed.2018.02.002_bib0065","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/annrheumdis-2011-200549","article-title":"An international registry on autoinflammatory diseases: the Eurofever experience","volume":"71","author":"Toplak","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2018.02.002_bib0070","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/annrheumdis-2014-206580","article-title":"Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers","volume":"74","author":"Federici","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2018.02.002_bib0075","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1136\/annrheumdis-2011-201271","article-title":"Guidelines for the genetic diagnosis of hereditary recurrent fevers","volume":"71","author":"Shinar","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2018.02.002_bib0080","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/art.39683","article-title":"Brief Report: Association of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome With Gonosomal Mosaicism of a Novel 24-Nucleotide TNFRSF1A Deletion","volume":"68","author":"Rowczenio","year":"2016","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.revmed.2018.02.002_bib0085","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1136\/ard.2005.048611","article-title":"Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene","volume":"65","author":"Ravet","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2018.02.002_bib0090","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/art.30237","article-title":"Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene","volume":"63","author":"Pelagatti","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2018.02.002_bib0095","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fimmu.2017.00299","article-title":"Disease phenotype and outcome depending on the age at disease onset in patients carrying the R92Q low-penetrance variant in TNFRSF1A Gene","volume":"8","author":"Ruiz-Ortiz","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.revmed.2018.02.002_bib0100","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1212\/01.wnl.0000436612.66328.8a","article-title":"Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus","volume":"81","author":"Ottoboni","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2018.02.002_bib0105","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/annrheumdis-2011-201268","article-title":"Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review","volume":"72","author":"Ter Haar","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2018.02.002_bib0110","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/annrheumdis-2015-207546","article-title":"Recommendations for the management of autoinflammatory diseases","volume":"74","author":"ter Haar","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2018.02.002_bib0115","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/rheumatology\/kev111","article-title":"On-demand treatment with anakinra: a treatment option for selected TRAPS patients","volume":"54","author":"Grimwood","year":"2015","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.revmed.2018.02.002_bib0120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00005792-200209000-00002","article-title":"The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder","volume":"81","author":"Hull","year":"2002","journal-title":"Med Baltim"},{"key":"10.1016\/j.revmed.2018.02.002_bib0125","first-page":"890","article-title":"Tumour necrosis factor receptor-associated periodic syndrome caused by a rare mutation in the TNFRSF1A gene, and with excellent response to etanercept treatment","volume":"27","author":"Cantarini","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2018.02.002_bib0130","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/039463201002300303","article-title":"Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature","volume":"23","author":"Cantarini","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.revmed.2018.02.002_bib0135","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/rheumatology\/kel298","article-title":"Failure of anti-TNF therapy in TNF Receptor 1-Associated Periodic Syndrome (TRAPS)","volume":"46","author":"Jacobelli","year":"2007","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.revmed.2018.02.002_bib0140","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/art.24294","article-title":"Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome","volume":"60","author":"Nedjai","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2018.02.002_bib0145","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.amjmed.2004.02.039","article-title":"Beneficial response to interleukin 1\u00a0receptor antagonist in traps","volume":"117","author":"Simon","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2018.02.002_bib0150","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/art.23475","article-title":"Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2018.02.002_bib0155","doi-asserted-by":"crossref","first-page":"907","DOI":"10.7326\/0003-4819-156-12-201206190-00027","article-title":"Successful treatment of tumor necrosis factor receptor-associated periodic syndrome with canakinumab","volume":"156","author":"Brizi","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2018.02.002_bib0160","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10067-014-2556-8","article-title":"Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate","volume":"34","author":"Lopalco","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2018.02.002_bib0165","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/annrheumdis-2015-209031","article-title":"Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study","volume":"76","author":"Gattorno","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2018.02.002_bib0170","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/art.30215","article-title":"Role of interleukin-6\u00a0in a patient with tumor necrosis factor receptor-associated periodic syndrome: assessment of outcomes following treatment with the anti-interleukin-6\u00a0receptor monoclonal antibody tocilizumab","volume":"63","author":"Vaitla","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2018.02.002_bib0175","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00296-015-3305-2","article-title":"Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS)","volume":"35","author":"La Torre","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.revmed.2018.02.002_bib0180","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1046\/j.1523-1755.2001.0590051677.x","article-title":"Autosomal-dominant periodic fever with AA amyloidosis: novel mutation in tumor necrosis factor receptor 1\u00a0gene Rapid Communication","volume":"59","author":"Jadoul","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.revmed.2018.02.002_bib0185","first-page":"543","article-title":"A complex case of renal amyloidosis with a rare co-occurrence of 2\u00a0mutations in separate hereditary periodic fever syndrome-related genes","volume":"19","author":"Cigni","year":"2006","journal-title":"J Nephrol"},{"key":"10.1016\/j.revmed.2018.02.002_bib0190","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ckj\/sft112","article-title":"Secondary amyloidosis in a patient carrying mutations in the familial Mediterranean fever (FMF) and tumour necrosis factor receptor-1\u00a0syndrome (TRAPS) genes","volume":"6","author":"Clementi","year":"2013","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.revmed.2018.02.002_bib0195","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/art.37827","article-title":"AA amyloidosis complicating the hereditary periodic fever syndromes","volume":"65","author":"Lane","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2018.02.002_bib0200","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/rheumatology\/keh357","article-title":"Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome","volume":"43","author":"Drewe","year":"2004","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.revmed.2018.02.002_bib0205","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.transproceed.2015.11.006","article-title":"Kidney Transplant in a Patient With Tumor Necrosis Factor Receptor-1\u00a0Syndrome (TRAPS): case report and review of the literature","volume":"48","author":"Rodziewicz","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.revmed.2018.02.002_bib0210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1515\/folmed-2016-0025","article-title":"First Case of TNF-Receptor-Associated Autoinflammatory Syndrome (TRAPS) in Bulgaria","volume":"58","author":"Solakov","year":"2016","journal-title":"Folia Med (Plovdiv)"},{"key":"10.1016\/j.revmed.2018.02.002_bib0215","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s10067-017-3688-4","article-title":"Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature","volume":"36","author":"Gentileschi","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2018.02.002_bib0220","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM200010053431412","article-title":"Treatment of the nephrotic syndrome with etanercept in patients with the tumor necrosis factor receptor-associated periodic syndrome","volume":"343","author":"Drewe","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2018.02.002_bib0225","first-page":"2519","article-title":"Two familial cases with tumor necrosis factor receptor-associated periodic syndrome caused by a non-cysteine mutation (T50M) in the TNFRSF1A gene associated with severe multiorganic amyloidosis","volume":"31","author":"Kallinich","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2018.02.002_bib0230","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1136\/ard.2007.079376","volume":"67","author":"Stojanov","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2018.02.002_bib0235","first-page":"119","article-title":"No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy","volume":"23","author":"Simsek","year":"2010","journal-title":"J Nephrol"},{"key":"10.1016\/j.revmed.2018.02.002_bib0240","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kex305","article-title":"International multi-centre study of pregnancy outcomes with interleukin-1\u00a0inhibitors","author":"Youngstein","year":"2017","journal-title":"Rheumatol Oxf Engl"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866318300389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866318300389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:38:47Z","timestamp":1759336727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866318300389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0248866318300389"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2018.02.002","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La fi\u00e8vre r\u00e9currente li\u00e9e au r\u00e9cepteur 1\u00a0du TNF (TNF receptor associated periodic syndrome \u2013\u00a0TRAPS)","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2018.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}